Author

Prateek Bhardwaj

Yale UniversityORCID 0000-0001-5546-7829Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2

Frequent Co-Authors

Ranjini K. SundaramiD· 2 shared Sam Friedman· 2 shared Ahmad KiwaniD· 1 shared Amro BaassiriiD· 1 shared Amy Yu· 1 shared Angela KimiD· 1 shared Charles BrenneriD· 1 shared Christine M. Heske· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ranjini K. SundaramORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 22, 2026

Biomarker-Targeted O6-Guanine Alkylation Potentiates ATR Inhibitor Response in De Novo and Relapsed/Refractory AML

Prateek Bhardwaj, Amro Baassiri, Ranjini K. Sundaram…·Ranjit S. Bindra

This study identifies MGMT silencing as a therapeutic target in AML and shows that combining O6-fluoroethylating agents with ATR inhibitors improves treatment outcomes.

DOI 10.64898/2026.09.19.751270

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedApr 22, 2026

NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition

Angela Kim, Prateek Bhardwaj, Collin D. Heer…·Juan C. Vasquez

This study evaluates NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitor therapy.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky